A detailed history of Lmr Partners LLP transactions in Repligen Corp stock. As of the latest transaction made, Lmr Partners LLP holds 24,167 shares of RGEN stock, worth $3.36 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
24,167
Holding current value
$3.36 Million
% of portfolio
0.03%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$119.79 - $167.35 $2.89 Million - $4.04 Million
24,167 New
24,167 $3.6 Million
Q4 2023

Feb 14, 2024

BUY
$114.17 - $185.35 $722,581 - $1.17 Million
6,329 Added 316.45%
8,329 $1.5 Million
Q3 2023

Nov 14, 2023

BUY
$138.78 - $176.51 $277,560 - $353,020
2,000 New
2,000 $318,000
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $1.97 Million - $3.14 Million
12,258 Added 451.33%
14,974 $2.8 Million
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $681,453 - $910,768
-4,844 Reduced 64.07%
2,716 $441,000
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $599,787 - $959,869
-3,721 Reduced 32.98%
7,560 $1.42 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $2.67 Million - $3.28 Million
-10,772 Reduced 48.85%
11,281 $2.99 Million
Q3 2021

Nov 15, 2021

BUY
$194.77 - $324.21 $4.3 Million - $7.15 Million
22,053 New
22,053 $6.37 Million
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $2.92 Million - $4.08 Million
-19,729 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$122.51 - $158.27 $426,457 - $550,937
-3,481 Reduced 15.0%
19,729 $2.91 Million
Q2 2020

Aug 14, 2020

BUY
$94.33 - $140.48 $2.19 Million - $3.26 Million
23,210 New
23,210 $2.87 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.71B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.